Michael P Citron
Overview
Explore the profile of Michael P Citron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
811
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Citron M, Zang X, Leithead A, Meng S, Rose Ii W, Murray E, et al.
J Infect
. 2024 Oct;
89(6):106325.
PMID: 39454831
Respiratory Syncytial Virus (RSV) causes severe respiratory infections and concomitant disease resulting in significant morbidity and mortality in infants, elderly, and immunocompromised adults. Vaccines, monoclonal antibodies, and small-molecule antivirals are...
2.
Nussbaum J, Cao X, Railkar R, Sachs J, Spellman D, Luk J, et al.
Vaccine
. 2023 Sep;
41(44):6488-6501.
PMID: 37777449
Human respiratory syncytial virus (RSV) causes a substantial proportion of respiratory tract infections worldwide. Although RSV reinfections occur throughout life, older adults, particularly those with underlying comorbidities, are at risk...
3.
Flynn J, Weber T, Cejas P, Cox K, Touch S, Austin L, et al.
Vaccine
. 2022 Jun;
40(32):4412-4423.
PMID: 35680500
In response to immune pressure, influenza viruses evolve, producing drifted variants capable of escaping immune recognition. One strategy for inducing a broad-spectrum immune response capable of recognizing multiple antigenically diverse...
4.
Zohar T, Hsiao J, Mehta N, Das J, Devadhasan A, Karpinski W, et al.
Cell Host Microbe
. 2021 Dec;
30(1):41-52.e5.
PMID: 34879230
Respiratory syncytial virus (RSV) infection is a major cause of respiratory illness in infants and the elderly. Although several vaccines have been developed, none have succeeded in part due to...
5.
Citron M, McAnulty J, Callahan C, Knapp W, Fontenot J, Morales P, et al.
Pathogens
. 2021 Nov;
10(11).
PMID: 34832599
One approach to protect new-borns against respiratory syncytial virus (RSV) is to vaccinate pregnant women in the last trimester of pregnancy. The boosting of circulating antibodies which can be transferred...
6.
Espeseth A, Cejas P, Citron M, Wang D, DiStefano D, Callahan C, et al.
NPJ Vaccines
. 2020 Mar;
5(1):16.
PMID: 32128257
The RSV Fusion (F) protein is a target for neutralizing antibody responses and is a focus for vaccine discovery; however, the process of RSV entry requires F to adopt a...
7.
Tang A, Chen Z, Cox K, Su H, Callahan C, Fridman A, et al.
Nat Commun
. 2019 Sep;
10(1):4153.
PMID: 31515478
Respiratory syncytial virus (RSV) infection is the leading cause of hospitalization and infant mortality under six months of age worldwide; therefore, the prevention of RSV infection in all infants represents...
8.
Citron M, Patel M, Purcell M, Lin S, Rubins D, McQuade P, et al.
Vaccine
. 2018 Mar;
36(20):2876-2885.
PMID: 29599087
Respiratory syncytial virus (RSV) is the most common viral cause of bronchiolitis and pneumonia in children twelve months of age or younger and a significant cause of lower respiratory disease...
9.
Wang D, Phan S, DiStefano D, Citron M, Callahan C, Indrawati L, et al.
J Virol
. 2017 Mar;
91(11).
PMID: 28298602
Human respiratory syncytial virus (RSV) is a common cause of severe respiratory disease among infants, immunocompromised individuals, and the elderly. No licensed vaccine is currently available. In this study, we...
10.
Bommakanti G, Lu X, Citron M, Najar T, Heidecker G, Ter Meulen J, et al.
J Virol
. 2012 Sep;
86(24):13434-44.
PMID: 23015722
The hemagglutinin protein (HA) on the surface of influenza virus is essential for viral entry into the host cells. The HA1 subunit of HA is also the primary target for...